K. Christopher Farkas
Known title: Vice President and CFOCIK: 0001621241
K. Christopher Farkas's purchase track record
How the stock did after each of K. Christopher Farkas's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since July 10, 2023
Stock higher 6 months later
100%
3 months: 75%
Median 6-month return
+27.1%
3 months: +13.0%
Beat the S&P 500
100%
median +15.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/6/2025 | CW | $9K | -18.0% | +40.1% | +4.3% |
| 7/3/2024 | CW | $12K | +24.4% | +29.2% | +6.0% |
| 1/4/2024 | CW | $10K | +17.7% | +25.0% | +18.7% |
| 7/10/2023 | CW | $11K | +8.3% | +16.5% | +8.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CW | ▲ Buy | Grant | 21 | $13K | 7/6/2026 | View on chart |
| CW | ▼ Sell | Open Market | 1,265 | $872K | 3/18/2026 | View on chart |
| CW | ▼ Sell | Open Market | 918 | $622K | 3/17/2026 | View on chart |
| CW | ▲ Buy | Option Exercise | 2,183 | $0 | 3/16/2026 | View on chart |
| CW | ▼ Sell | Open Market | 3,105 | $2.2M | 2/18/2026 | View on chart |
| CW | ▼ Sell | Open Market | 2,665 | $1.7M | 2/4/2026 | View on chart |
| CW | ▲ Buy | Grant | 5,770 | $3.9M | 2/3/2026 | View on chart |
| CW | ▲ Buy | Grant | 17 | $8K | 1/5/2026 | View on chart |
| CW | ▼ Sell | Open Market | 5,047 | $2.9M | 11/11/2025 | View on chart |
| CW | ▲ Buy | Grant | 30 | $12K | 7/2/2025 | View on chart |
| CW | ▼ Sell | Open Market | 4,780 | $1.7M | 5/1/2025 | View on chart |
| CW | ▼ Sell | Open Market | 922 | $300K | 3/18/2025 | View on chart |
| CW | ▲ Buy | Option Exercise | 2,243 | $0 | 3/17/2025 | View on chart |
| CW | ▼ Sell | Open Market | 2,453 | $851K | 2/5/2025 | View on chart |
| CW | ▲ Buy | Grant | 5,912 | $2.0M | 2/4/2025 | View on chart |
| CW | ▲ Buy | Open Market | 30 | $9K | 1/6/2025 | View on chart |
| CW | ▲ Buy | Open Market | 51 | $12K | 7/3/2024 | View on chart |
| CW | ▼ Sell | Open Market | 880 | $215K | 3/20/2024 | View on chart |
| CW | ▲ Buy | Grant | 1,805 | $0 | 3/19/2024 | View on chart |
| CW | ▼ Sell | Open Market | 925 | $225K | 3/19/2024 | View on chart |
| CW | ▼ Sell | Open Market | 2,736 | $657K | 3/14/2024 | View on chart |
| CW | ▲ Buy | Grant | 4,742 | $1.1M | 2/8/2024 | View on chart |
| CW | ▼ Sell | Open Market | 2,006 | $451K | 2/8/2024 | View on chart |
| CW | ▲ Buy | Open Market | 51 | $10K | 1/4/2024 | View on chart |
| CW | ▲ Buy | Open Market | 73 | $11K | 7/10/2023 | View on chart |
| CW | ▼ Sell | Other | 2,018 | $0 | 3/21/2023 | View on chart |
| CW | ▼ Sell | Other | 875 | $150K | 3/21/2023 | View on chart |
| CW | ▲ Buy | Grant | 3,280 | $559K | 2/15/2023 | View on chart |
| CW | ▼ Sell | Open Market | 1,525 | $258K | 2/15/2023 | View on chart |
| CW | ▲ Buy | Grant | 80 | $11K | 1/4/2023 | View on chart |
| CW | ▲ Buy | Grant | 88 | $10K | 7/7/2022 | View on chart |
| CW | ▼ Sell | Other | 952 | $138K | 3/15/2022 | View on chart |
| CW | ▼ Sell | Open Market | 435 | $63K | 3/15/2022 | View on chart |
| CW | ▼ Sell | Open Market | 530 | $73K | 2/16/2022 | View on chart |
| CW | ▲ Buy | Grant | 1,037 | $143K | 2/16/2022 | View on chart |
| CW | ▲ Buy | Grant | 84 | $10K | 1/6/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Curtiss-Wright (CW) Eyes Earnings Beat, Adds Nuclear Simulator
Analysts are questioning whether Curtiss-Wright will again exceed earnings estimates in its upcoming report. The company also installed a Stage 1 simulator at TerraPower’s Natrium nuclear site in Kemmerer, Wyoming, highlighting its involvement in advanced reactor development. These developments keep the stock in focus as it trades near the lower end of its 52‑week range.
Curtiss-Wright (CW) Eyes Earnings Beat, Adds Nuclear Simulator. Analysts are questioning whether Curtiss-Wright will again exceed earnings estimates in its upcoming report. The company also installed a Stage 1 simulator at TerraPower’s Natrium nuclear site in Kemmerer, Wyoming, highlighting its involvement in advanced reactor development. These developments keep the stock in focus as it trades near the lower end of its 52‑week range.